Related references
Note: Only part of the references are listed.
Review
Oncology
Early Palliative Care in Acute Myeloid Leukemia
Leonardo Potenza et al.
Summary: New targeted drugs have been developed for AML treatment, but their potential efficacy needs to be balanced with the possibility of poor outcomes. Early integration of PC has shown benefits for solid tumor patients, but is underutilized in patients with hematologic malignancies.
CANCERS (2022)
Review
Oncology
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment
David C. de Leeuw et al.
Summary: The treatment of elderly patients with acute myeloid leukemia is a challenge due to patient diversity and disease heterogeneity. Determining fitness and selecting appropriate treatments based on factors like age, performance status, and comorbidities is important. Recent developments such as the addition of venetoclax, targeted therapy with IDH1/2 and FLT3 inhibitors, and improved formulations of existing drugs have improved treatment outcomes. Selecting patient-tailored treatments based on fitness and disease biology is essential.
CURRENT ONCOLOGY REPORTS (2022)
Share Paper
